Mankind Pharma to acquire BSV for ₹13,630 crore
The Hindu
Mankind Pharma acquires Bharat Serums and Vaccines, becoming a market leader in women's health and fertility segment.
Mankind Pharma Ltd said it had entered into a definitive agreement to acquire a 100% stake in Bharat Serums and Vaccines Ltd (BSV) from private equity firm Advent International for an enterprise value of about ₹13,630 crore subject to closing related adjustments.
“This strategic move marks a significant leap for Mankind Pharma, positioning it as a market leader in the Indian women’s health and fertility drug market alongside access to other high entry barrier products in critical care with established complex R&D tech platforms, the company said in a statement.
BSV has a portfolio offering in Women’s Health, encompassing the entire lifecycle – from fertility to post-pregnancy.
Rajeev Juneja, Vice-chairman and Managing Director, Mankind Pharma said, “BSV’s acquisition represents a pivotal milestone in Mankind’s journey, establishing us as market leader in Indian women’s health & fertility segment.”
“We believe women’s health & fertility segment has massive opportunity along with strong growth visibility globally, led by structural tailwinds,” he added.
“BSV’s established Specialty R&D Tech Platforms with complex portfolio across Women’s health, Fertility, critical care and Immunoglobulin segment perfectly aligns Mankind Pharma’s strategic vision to expand its footprint in high entry barrier portfolio,” he further said.
Shweta Jalan, Managing Partner and Head of Advent India in a statement said, “Mankind’s investment in BSV is a testament to our approach of identifying and nurturing unique businesses, working with high-quality management teams and building these businesses into respected industry leaders.”
Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.
The Rupee appreciated by 19 paise to close at 89.96 against the U.S. dollar amid weak dollar index support.
India aims to expand its tea exports to China, highlighting diverse varieties like Darjeeling and Masala at a recent buyer-seller meet.
Stock markets rebound after four days of decline as Sensex rises 158 points, driven by tech and IT shares.
India reduces Russian oil imports by 38% in October 2025, marking the sharpest decline in value and volume yet.
Suzlon announces three new AI-enabled smart blade factories, expanding its manufacturing footprint to 20 facilities in India.
Odisha Government terminates Silicon Tech Lab's empanelment for involvement in a recruitment scam and service agreement violations.
Worli, Mumbai, dominates India’s ultra-luxury apartment market, accounting for 40% of transactions worth ₹5,500 crore in two years.
IndiGo faces disruptions due to a hiring freeze, prompting pilots' body to urge regulatory intervention for safe operations.
Nvidia CEO Jensen Huang met separately with U.S. President Donald Trump and Republican senators Wednesday
Rupee falls to 90.43 against the dollar amid RBI's restrained intervention and high importer demand, causing market concerns.
Meta’s poaching of Apple's Alan Dye underscores its push to expand consumer hardware beyond its smart glasses
Airbus orders upgrades for 6,000 A320 aircraft after a JetBlue incident raises concerns about software vulnerability to solar radiation.